Nuclea Biotechnologies | GenomeWeb

Nuclea Biotechnologies

Under the partnership the two companies will develop assays for insulin, proinsulin, and c-peptide on clinical sample cohorts at both Nuclea and IRCM's facilities.

The company will focus largely on applying mass spec to relatively established protein markers for which existing immunoassay-based tests have poor performance.

The arrangement will join Nuclea's expertise in proteomics with Aelan's genomics know-how.

The firm is now clinically validating a mass spec-based test for quantifying native insulin and its therapeutic analogs and another test for type 2 diabetes. 

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and Nuclea Biotechnologies said this week they are collaborating on mass spec-based assays for quantification of native insulin and its therapeutic analogs.

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies and Thermo Fisher Scientific said today that they are collaborating on multiplexed mass spec assays for quantifying native insulin and its therapeutic analogs.

NEW YORK (GenomeWeb) – Nuclea Biotechnologies today said it has inked an agreement with Clinical Reference Laboratory to validate three of Nuclea's tests.

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies this week announced Immuno-Biological Laboratories will be the primary US distributor of Nuclea's HER-2/neu kits.
Nuclea and IBL also will coordinate joint marketing efforts for the serum HER-2/neu kits as part of the deal.

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has released the list of firms that will receive a total of $25 million in tax incentives tied to job creation this year, and that list includes several omics and molecular diagnostics firms.

NEW YORK (GenomeWeb News) – Enzo Clinical Labs and Nuclea Biotechnologies have entered into an agreement to market Nuclea's non-invasive HER-2/neu serum test for monitoring metastatic breast cancer, Enzo Biochem announced today.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.